dr. tripathy on combination strategies with cdk4/6 inhibitors in hr breast cancer
Published 6 years ago • 56 plays • Length 1:21Download video MP4
Download video MP3
Similar videos
-
1:47
dr. tripathy on combination strategies with cdk4/6 inhibitors in breast cancer
-
0:22
copy of dr. tripathy on combination strategies with cdk4/6 inhibitors in hr breast cancer
-
4:52
cdk4/6 inhibitor combinations for hr mbc
-
4:35
hr breast cancer: differences between cdk4/6 inhibitors
-
1:08
overcoming resistance to cdk4/6 inhibitors in er breast cancer via ctdna
-
2:17
dr. goetz on treatment beyond progression on cdk4/6 inhibitors in hr breast cancer
-
4:15
hr breast cancer: factors in selecting a cdk4/6 inhibitor
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
17:54
expert perspectives: cdk 4/6 inhibitors for er breast cancer: current data and clinical use
-
7:40
cdk4/6 inhibitors in the first-line treatment setting
-
5:23
emerging cdk4/6-targeted therapy for breast cancer
-
3:27
metastatic breast cancer: cdk4/6 inhibitors
-
26:34
cdk 4/6 inhibitors in breast cancer advanced and adjuvant settings
-
2:00
dr. tripathy on personalized therapy options in metastatic breast cancer
-
7:58
cdk 4/6 inhibitors: how are they used in metastatic breast cancer treatment?
-
3:01
resistance to adcs in breast cancer and novel combination strategies
-
1:52
dr. tripathy discusses the monaleesa-7 trial in hr breast cancer
-
4:54
monarch 3 study: cdk4/6 inhibitors in the treatment of metastatic breast cancer
-
20:19
expert discussion on cdk 4/6 inhibition in breast cancer